GCA and hyperlipidemia: This modulation significantly reduces free bile acid levels (including LCA, HDCA, CDCA, UDCA, and DCA; p < 0.05) and upregulates conjugated bile acids (TCA, GCA, TCDCA, TDCA, and TUDCA; 0.05 < p < 0.1), thereby effectively improving hyperlipidemia.